BrightOwl Loader Loading

Summary

+ business and client orientated, i like working in a scientific environment, which includes learning and development opportunities. currently, this environment enables me to apply my scientific and management competences in the drug-market -access matter. + over the years i have acquired an expertise in general pharmacology related to Diabetes and metabolic diseases, oncology and Hematology, with a special focus in bacterial Infectious diseases: set up for a team of a new Research pathway within the field of anti-infective pharmacology. this provided answers with innovative in-vitro cellular models upcoming questions related to potential effects of transporters on antibiotics: (i) cellular Pharmacokinetics parameters. (ii) pharmacodynamic profile towards intracellular infection. (iii) toxicodynamic potential on Bacteria-infected cells. + self-motivated team player, focused and quick learner with a good oral and written Communication ability. + solid experience in (bio)analytical development and Validation methods for both Small molecules and Proteins. + demonstrated technical and Problem-solving skills with a significant of scientific accomplishments: 7 published papers on peer-reviewed journals and 12 communications. prix de la fondation belge de la vocation (f.b.v), fellowship isap (international society of applied pharmacology) to attend toronto iccac . specialties: transporters (influx/efflux) and drug drug interactions (ddis). characterisation of Preclinical admet drugs properties. antibiotics, intracellular infections, expertise in culturing cellular processes pharmacokinetic, pharmacodynamic,toxicodynamic drugs transporters mediated resistance mechanisms

Experiences

Current Experience

  • Expert for the Belgian Medicine Reimbursement Committee at National Institute for Health& Disability


    Since January 2011
    evaluator in drug-Market access (Reimbursement procedure) for the "commission de remboursement des médicaments" with a focus in Diabetes, metabolic diseases, oncology, Hematology and Infectious diseases and special interest in hta (Health technology assessment). Evaluator in drug-market access (reimbursement procedure) for the "Commission de Remboursement des Médicaments" with a focus in diabetes, metabolic diseases, oncology, hematology and infectious diseases and special interest in HTA (Health Technology Assessment).

Past Experience

  • Project and team management in Biotechnology (FOREM Biotechnology training center, GIGA, Liège)

    September 2010 --- December 2010

  • Conception and redaction of a business plan to set-up a firm related to health products & allergy

    January 2008 --- January 2010

  • Researcher Pharmacist - Project Manager in anti-infective pharmacology

    January 2000 --- January 2007
    plan, conduct & supervise a project in a small Research team :cellular & Molecular Pharmacology unit (facm), ucl. prof. tulkens.  assessment of drug transporters effects on pharmacokinetic, pharmacodynamic and toxicodynamic properties of anti-infective drugs belonging to several antibiotic families.  characterisation of drugs properties either in Preclinical or Clinical Development.  inclusion in Project Management boards to support R&D and Preclinical efforts for Pharmaceutical companies (lilly, bayer).  experience of Education and formation: • Teaching in normal & special pharmacology. • Tutor and train technicians, undergraduate students and graduate researchers. • workshops design, presentation and animation for post-University Pharmacists.  Analysis of results, writing of projects and Research reports ( 5 peer-reviewed papers and 8 communications).

  • Junior research investigator

    January 1998 --- January 2000
     provide Leadership and strategic vision for the set up of a new Research activity in anti-infective pharmacology: • project initiation and implementation.  redaction and submission of a Research project for granting processes: • bayer (100.keuros) and ucl (100.keuros). • writing of 1 peer-reviewed paper & 4 communications .

Knowledge

LinkedIn Assessment :
CellIn VitroDrug DevelopmentGood Laboratory Practice (GLP)Protein chemistryGCPInfectious diseasesClinical researchGMPValidationAnalytical ChemistryPharmacistsMedicinePharmaceutical IndustryClinical trialsResearchmolecular biologyoncologyHealthcareCell biology

Education

  • Training in biotechnology project and team management (GIGA Biotechnology training center, Liège). in from Université de Liège in 2011
  • Special degree in business management in Economie Sociale from Université libre de Bruxelles in 2009
  • PhD - Cellular and Molecular Pharmacology - GD - in Infectiology - PK/PD/TD - Development and validation of bacteria-(un)infected in-vitro models from Université catholique de Louvain in 2007
  • Complementary Master in Pharmaceutical Sciences - GD - in Pharmacology, Infectiology, eukaryotic in-vitro models from Université catholique de Louvain in 2000
  • PharmD in Epreuves du grade de Pharmacien - D - from Université catholique de Louvain in 1997

Languages

BrightOwl Assessment:
Self Assessment:
French
Native

Area / Region

Walhain-Saint-Paul, Walhain, Belgium

Others

Driving License
  • Yes

Similar Candidates

Other Candidates in Belgium

Other Candidates in Walhain

Other Candidates

Most Recent Searches

Most Famous Searches

You might also like